T-705 (Favipiravir) 50mg 50mg | Purity Not Available
Adooq Bioscience
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
More Information Supplier PageSearch Results
T-705 (Favipiravir) 25mg 25mg | Purity Not Available
Adooq Bioscience
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
More Information Supplier PageT-705 (Favipiravir) 100mg 100mg | Purity Not Available
Adooq Bioscience
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
More Information Supplier PageT-705 (Favipiravir) 10mg 10mg | Purity Not Available
Adooq Bioscience
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
More Information Supplier PageTAK-715 50mg 50mg | Purity Not Available
Adooq Bioscience
TAK 715 an inhibitor of p38 MAPK (IC50 = 7.1 nM for p38 MAPK??), Wnt/beta-catenin signaling, and Inhibits 22 kinases by more than 80%, including CK 1??/??.
More Information Supplier PageTAK-715 25mg 25mg | Purity Not Available
Adooq Bioscience
TAK 715 an inhibitor of p38 MAPK (IC50 = 7.1 nM for p38 MAPK??), Wnt/beta-catenin signaling, and Inhibits 22 kinases by more than 80%, including CK 1??/??.
More Information Supplier PageTAK-715 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
TAK 715 an inhibitor of p38 MAPK (IC50 = 7.1 nM for p38 MAPK??), Wnt/beta-catenin signaling, and Inhibits 22 kinases by more than 80%, including CK 1??/??.
More Information Supplier PageTAK-715 100mg 100mg | Purity Not Available
Adooq Bioscience
TAK 715 an inhibitor of p38 MAPK (IC50 = 7.1 nM for p38 MAPK??), Wnt/beta-catenin signaling, and Inhibits 22 kinases by more than 80%, including CK 1??/??.
More Information Supplier PageTAK-715 10mg 10mg | Purity Not Available
Adooq Bioscience
TAK 715 an inhibitor of p38 MAPK (IC50 = 7.1 nM for p38 MAPK??), Wnt/beta-catenin signaling, and Inhibits 22 kinases by more than 80%, including CK 1??/??.
More Information Supplier PageToceranib (PHA 291639, SU 11654) 50mg 50mg | Purity Not Available
Adooq Bioscience
Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFR??.
More Information Supplier Page